Answers are grounded in this paper and cite their sources.
Thirty-eight healthy subjects were given single oral doses of debrisoquine and sparteine in a crossover study. The close correlation between urinary metabolic ratios of the two drugs (rs = 0.91; P less than 0.001) demonstrates that the polymorphic N-oxidation of sparteine and 4-hydroxylation of debrisoquine are related pharmacogenetic entities; the metabolism of the two drugs is regulated by identical or closely related genetic factors.
No takes yet. Share an insight, caveat, or question.
Eichelbaum et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: